Microbiota-Based Therapy for the Prevention of Recurrent Clostridioides difficile Infection:
A Primer on REBYOTA^®
(fecal microbiota, live-jslm)

Microbiota-Based Therapy for the Prevention of Recurrent Clostridioides difficile Infection: A Primer on REBYOTA? (fecal microbiota, live-jslm) Faculty Sahil Khanna, MBBS, MS Professor of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine Mayo Clinic Rochester, Minnesota David W. Hines, MD, FACP Infectious Disease Physician Metro Infectious Disease Consultants Chicago, Illinois Nicholas Van Hise, PharmD, BCPS Director of Clinical Research Infectious Disease